Gastroparesis: Medical Treatments
The question
To ask the Secretary of State for Health and Social Care, whether his Department has made a comparative assessment of access to gastric electrical stimulation for gastroparesis patients in England, Scotland, Wales and Northern Ireland; and what steps he is taking to address regional disparities in access to this treatment.
Answered by Mrs Sharon Hodgson
The Government remains committed to improving outcomes for people living with rare diseases, including gastroparesis, through the UK Rare Diseases Framework and England Rare Diseases Action Plans. Faster diagnosis is a priority under the framework. Patients with suspected gastroparesis typically undergo blood tests and imaging to exclude other causes, followed, where necessary, by a gastroscopy and tests to assess how quickly food passes through the stomach. Integrated care boards commission all services for patients with gastroparesis, with the exception of gastro-electrical stimulation, which falls within the remit of nationally commissioned services.
Addressing health inequalities for people living with rare conditions is a priority under the UK Rare Diseases Framework. In the 2026 England Rare Diseases Action Plan, we introduced a new and important action to address health inequalities for rare diseases through the Core20PLUS5 Framework. However, there has not been a formal comparative assessment across the four nations in relation to their respective National Health Service provision of gastroparesis services and treatment.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →